Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for tough cancers: experimental drug IMGS-001 enters human trials

NCT ID NCT06014502

Recruiting now Disease control Sponsor: ImmunoGenesis Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This early-stage study tests an experimental drug called IMGS-001 in about 105 people with advanced solid tumors that have come back or not improved after standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. The study has two parts: first, testing different doses for safety, then testing the best doses in specific cancer types like ovarian cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer classic Hodgkin lymphoma colorectal cancer fallopian tube cancer head and neck cancer head and neck squamous cell carcinoma nasopharyngeal carcinoma nasopharyngeal carcinoma, susceptibility to, 1 neoplasm non-small cell lung carcinoma ovarian cancer primary mediastinal large B-cell lymphoma primary peritoneal carcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOLID TUMOR

Contacts and locations

Locations

  • Banner MD Anderson Cancer Center

    RECRUITING

    Gilbert, Arizona, 85234, United States

    Contact Email: •••••@•••••

  • Fox Chase Cancer Center

    RECRUITING

    Philadelphia, Pennsylvania, 19111, United States

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

  • NEXT Dallas

    RECRUITING

    Irving, Texas, 75039, United States

  • Ochsner Clinic Foundation

    RECRUITING

    New Orleans, Louisiana, 70121, United States

  • Sarcoma Oncology Center

    RECRUITING

    Santa Monica, California, 90403, United States

  • St. Elizabeth Healthcare

    RECRUITING

    Edgewood, Kentucky, 41017, United States

  • UC Irvine

    RECRUITING

    Orange, California, 92868, United States

    Contact Email: •••••@•••••

  • UPMC Hillman Cancer Center

    RECRUITING

    Pittsburgh, Pennsylvania, 15232, United States

  • WashU

    RECRUITING

    St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.